Key Takeaways
- • Regal Partners' flagship hedge fund fell about 19 per cent over the past year, according to the Australian Financial Review, a tough result in a difficult ASX year for the fund.
- • Challenger shares rose after receiving a bid from TAL Daiichi, the AFR reported, though the article provided limited detail on bid terms in the primary source.
- • An executive health trend is dividing doctors and performance coaches, the AFR's daily brief said, with the debate centred on its merits for senior leaders.
Summary
In a separate development, Challenger shares jumped after a bid from TAL Daiichi emerged. The AFR's coverage in the primary source is brief, and the article does not set out the bid price, structure or conditions in the material available. Readers seeking deal terms should consult the full AFR report.
The third item covers an executive health trend that the AFR says divides doctors and performance coaches. The source frames this as a debate over the approach's value for senior executives rather than reporting a specific policy or corporate action.
The primary source is a short newsletter-style digest, and the supporting material available for this story does not add further verifiable detail on these items. The summary therefore reflects the key claims as reported and avoids extrapolating beyond them.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.